Last reviewed · How we verify
Diclegis
At a glance
| Generic name | Diclegis |
|---|---|
| Also known as | Active |
| Sponsor | Duchesnay Inc. |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Therapeutic Implications of Acutaping on Nausea and Vomiting During Pregnancy (NA)
- A Multicenter Trial of the Efficacy and Safety of Diclegis® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents (PHASE4)
- A Study to Investigate Differences in the Extent and Rate of Absorption of Doxylamine/Pyridoxine From 2 Different Products Under Fasting Conditions (PHASE1)
- Ondansetron VS Doxylamine and Pyridoxine in Treating Nausea of Pregnancy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diclegis CI brief — competitive landscape report
- Diclegis updates RSS · CI watch RSS
- Duchesnay Inc. portfolio CI